Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue (Q46505744)

22 December 2017

title

Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue (English)

1 reference

22 December 2017

1 reference

1 reference

Mi H Lee

1

1 reference

22 December 2017

Hye K Song

2

1 reference

22 December 2017

Gang J Ko

3

1 reference

22 December 2017

Young S Kang

4

1 reference

22 December 2017

Sang Y Han

5

1 reference

22 December 2017

Kum H Han

6

1 reference

22 December 2017

Hyoung K Kim

7

1 reference

22 December 2017

Jee Y Han

8

1 reference

22 December 2017

Dae R Cha

9

1 reference

22 December 2017

language of work or name

English

0 references

publication date

2 July 2008

1 reference

22 December 2017

published in

Kidney International

1 reference

22 December 2017

volume

74

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

890-900

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2008.313

exact match

0 references

cites work

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Role of the renin-angiotensin- aldosterone system in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Development of insulin-responsive glucose uptake and GLUT4 expression in differentiating human adipocyte precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

The morphology and metabolism of intraabdominal adipose tissue in men

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Adiponectin differentially regulates cytokines in porcine macrophages

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Cellular Carbonyl Stress Enhances the Expression of Plasminogen Activator Inhibitor-1 in Rat White Adipocytes via Reactive Oxygen Species-dependent Pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

A central role for JNK in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Isoproterenol inhibits resistin gene expression through a G(S)-protein-coupled pathway in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Use of genetically altered mice to investigate the role of nuclear factor-kappa B activation and cytokine gene expression in sepsis-induced ARDS

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.313

7 January 2021

Identifiers

DOI

10.1038/KI.2008.313

1 reference

22 December 2017

PubMed ID

18596725

1 reference

22 December 2017